These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21356230)

  • 1. The corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, prevent stress-induced cognitive impairment in mice.
    Urani A; Philbert J; Cohen C; Griebel G
    Pharmacol Biochem Behav; 2011 May; 98(3):425-31. PubMed ID: 21356230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the rat.
    Louis C; Cohen C; Depoortère R; Griebel G
    Neuropsychopharmacology; 2006 Oct; 31(10):2180-7. PubMed ID: 16452986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the vasopressin (V1b) receptor antagonist, SSR149415, and the corticotropin-releasing factor 1 receptor antagonist, SSR125543, on FG 7142-induced increase in acetylcholine and norepinephrine release in the rat.
    Claustre Y; Rouquier L; Desvignes C; Leonetti M; Montégut J; Aubin N; Allouard N; Bougault I; Oury-Donat F; Steinberg R
    Neuroscience; 2006 Sep; 141(3):1481-8. PubMed ID: 16781820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression.
    Alonso R; Griebel G; Pavone G; Stemmelin J; Le Fur G; Soubrié P
    Mol Psychiatry; 2004 Mar; 9(3):278-86, 224. PubMed ID: 14699428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of vasopressin 3 receptors in chronic psychological stress-induced visceral hyperalgesia in rats.
    Bradesi S; Martinez V; Lao L; Larsson H; Mayer EA
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G302-9. PubMed ID: 19033533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression.
    Overstreet DH; Griebel G
    Eur J Pharmacol; 2004 Aug; 497(1):49-53. PubMed ID: 15321734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal.
    Surget A; Saxe M; Leman S; Ibarguen-Vargas Y; Chalon S; Griebel G; Hen R; Belzung C
    Biol Psychiatry; 2008 Aug; 64(4):293-301. PubMed ID: 18406399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CRF₁ receptor antagonist SSR125543 attenuates long-term cognitive deficit induced by acute inescapable stress in mice, independently from the hypothalamic pituitary adrenal axis.
    Philbert J; Pichat P; Palme R; Belzung C; Griebel G
    Pharmacol Biochem Behav; 2012 Sep; 102(3):415-22. PubMed ID: 22659580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CRF₁ receptor antagonist SSR125543 prevents stress-induced cognitive deficit associated with hippocampal dysfunction: comparison with paroxetine and D-cycloserine.
    Philbert J; Belzung C; Griebel G
    Psychopharmacology (Berl); 2013 Jul; 228(1):97-107. PubMed ID: 23407783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of Stress-Induced ACTH Secretion by Vasopressin and CRH: Additional Evidence.
    Ramos AT; Tufik S; Troncone LR
    Neuropsychobiology; 2016; 73(3):184-90. PubMed ID: 27221315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression.
    Hodgson RA; Higgins GA; Guthrie DH; Lu SX; Pond AJ; Mullins DE; Guzzi MF; Parker EM; Varty GB
    Pharmacol Biochem Behav; 2007 Mar; 86(3):431-40. PubMed ID: 17291571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant-like effects of the vasopressin V1b receptor antagonist SSR149415 in the Flinders Sensitive Line rat.
    Overstreet DH; Griebel G
    Pharmacol Biochem Behav; 2005 Sep; 82(1):223-7. PubMed ID: 16181667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pituitary mediates the anxiolytic-like effects of the vasopressin V1B receptor antagonist, SSR149415, in a social interaction test in rats.
    Shimazaki T; Iijima M; Chaki S
    Eur J Pharmacol; 2006 Aug; 543(1-3):63-7. PubMed ID: 16843459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the CRF1 receptor antagonist SSR125543 on energy balance and food deprivation-induced neuronal activation in obese Zucker rats.
    Doyon C; Samson P; Lalonde J; Richard D
    J Endocrinol; 2007 Apr; 193(1):11-9. PubMed ID: 17400798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of adrenocorticotrophic hormone secretion by simultaneous antagonism of vasopressin 1b and CRH-1 receptors on three different stress models.
    Ramos AT; Troncone LR; Tufik S
    Neuroendocrinology; 2006; 84(5):309-16. PubMed ID: 17135717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders.
    Serradeil-Le Gal C; Wagnon J; Tonnerre B; Roux R; Garcia G; Griebel G; Aulombard A
    CNS Drug Rev; 2005; 11(1):53-68. PubMed ID: 15867952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.
    Griebel G; Simiand J; Serradeil-Le Gal C; Wagnon J; Pascal M; Scatton B; Maffrand JP; Soubrie P
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6370-5. PubMed ID: 11959912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of osmotic and SSR149415 challenges in maternally separated and control rats: the role of vasopressin on spatial learning.
    Hernandez VS; Ruíz-Velazco S; Zhang L
    Neurosci Lett; 2012 Oct; 528(2):143-7. PubMed ID: 22982556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CRF₁ receptor antagonist SSR125543 prevents stress-induced long-lasting sleep disturbances in a mouse model of PTSD: comparison with paroxetine and d-cycloserine.
    Philbert J; Beeské S; Belzung C; Griebel G
    Behav Brain Res; 2015 Feb; 279():41-6. PubMed ID: 25446760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An arginine vasopressin V1b antagonist, SSR149415 elicits antidepressant-like effects in an olfactory bulbectomy model.
    Iijima M; Chaki S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):622-7. PubMed ID: 17229509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.